Tesamorelin (Egrifta)

Product Description

Product Name:Tesamorelin(Egrifta)

Synonym:Tesamorelin;804475-66-9;218949-48-5;Egrifta;Tesamorelin;Th 9507;Th-9507;Unii-mqg94m5eeo;

Molecular Formula:C221H366N72O67S

Formula Weight:5135.77794

CAS No.:804475-66-9/218949-48-5

Description:Tesamorelin (INN) (trade name Egrifta) is a synthetic form of growth-hormone-releasing hormone (GHRH) which is used in the treatment of HIV-associated lipodystrophy. It is produced and developed by Theratechnologies, Inc. of Canada.

Tesamorelin is a synthetic peptide consisting of all 44 amino acids of human GHRH with the addition of a trans-3-hexenoic acid group

Tesamorelin is used for Reducing excess stomach fat in certain HIV-infected patients.

Tesamorelin is a human growth hormone-releasing factor (GRF) analog. It works by stimulating the pituitary gland to release growth hormone (GH). This causes the breakdown of excess stomach fat.